Skip to Content

immunotherapy

https://youtu.be/aqwBBnBspwk

In the late 1960s, a group of scientists and volunteers at UCLA came together to develop a cancer center they hoped would become renowned for excellence in research, education and patient care. Today, UCLA Health’s Jonsson [...]

By uclahealth • November 13, 2019

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma.

What is CAR T-cell therapy?

Immunotherapy [...]

By uclahealth • October 7, 2019

In 2015, ESPN reporter Holly Row was diagnosed with desmoplastic melanoma, a rare, fast-spreading form of skin cancer. After a first surgery, she enrolled in a UCLA clinical trial led by Dr. Antoni Ribas testing a new approach [...]

By uclahealth • July 18, 2019

Medical researchers have had breakthroughs in treating certain types of cancer by bolstering a patient’s immune system. Known as immunotherapy, or biologic therapy, it treats cancer differently than established treatments such as chemotherapy, radiation, bone marrow transplant and surgery.

To date, the U.S. Food and [...]

By uclahealth • February 11, 2019
Good news: Cancer survival rates are improving. The five-year cancer survival rate has risen from 49 percent in the mid-1970s to 69 percent in 2013,
By Tiare Dunlap • September 25, 2017

Jeannine Walston shares her story, with detailed information about her experience at UCLA, Dr. Liau, brain surgery, immunotherapy vaccine, and how to support research.

By jwals • November 30, 2016
In the summer of 2015, a brand-new cancer therapy known as “Jimmy Carter’s cancer drug” shot to fame. Called pembrolizumab, it was instrumental in former President Jimmy Carter’s successful treatment for metastatic melanoma. Previously, patients with metastatic melanoma (skin cancer that has spread to other areas of the [...]
By uclahealth • June 7, 2016
Colored coronal magnetic resonance imaging (MRI) scan through the head of a 48-year-old male patient with a glioblastoma (red), with surrounding oedema (fluid) that is compressing the left ventricle (at right). A glioblastoma is a particularly malignant brain cancer that arises from the supporting glial cells in [...]
By uclahealth • April 26, 2016